Repligen (RGEN) Net Cash Flow Growth (3y) (2013 - 2026)
Repligen (RGEN) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 65.71% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.60% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -339.28% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -242.00% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 78.59% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 36.96% |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | -35.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.32% |
| Mar 31, 2026 | 63.77% |
| Dec 31, 2025 | -45.22% |
| Sep 30, 2025 | 67.44% |
| Jun 30, 2025 | -14.81% |
| Mar 31, 2025 | -55.30% |
| Dec 31, 2024 | -24.78% |
| Sep 30, 2024 | 38.12% |
| Jun 30, 2024 | 11.75% |
| Mar 31, 2024 | 228.52% |
| Dec 31, 2023 | -6.44% |
| Sep 30, 2023 | 69.27% |
| Jun 30, 2023 | 77.91% |
| Mar 31, 2023 | -48.72% |
| Dec 31, 2022 | -97.89% |
| Sep 30, 2022 | -26.99% |
| Jun 30, 2022 | -5.58% |
| Mar 31, 2022 | -69.29% |
| Dec 31, 2021 | -134.41% |
| Sep 30, 2021 | -105.90% |